CureAge Therapeutics Revenue

Biotechnology Research • • 1-10 Employees

CureAge Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at CureAge Therapeutics

Kerstin Papenfuss

Director

Company overview

Headquarters	XX
Website	cureagetx.com
NAICS	541714
Founded	2024
Employees	1-10

CureAge Therapeutics Email Formats

CureAge Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@cureagetx.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@cureagetx.com	100%

About CureAge Therapeutics

We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1). Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first curative therapy for NF1 and other Schwann cell-related disorders.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

CureAge Therapeutics has never raised funding before.

Frequently asked questions

CureAge Therapeutics is located in XX.

CureAge Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

CureAge Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CureAge Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

CureAge Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at CureAge Therapeutics

Kerstin Papenfuss

Director

4.8

40,000 users